Xenon Pharmaceuticals
XENE
XENE
213 hedge funds and large institutions have $2.89B invested in Xenon Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 78 increasing their positions, 71 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $3.16B → $2.89B (-$272M)
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
22% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 27
Holders
213
Holding in Top 10
8
Calls
$10.5M
Puts
$3.54M
Top Buyers
| 1 | +$48.8M | |
| 2 | +$22.9M | |
| 3 | +$14.6M | |
| 4 |
O
OrbiMed
New York
|
+$12.2M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$11.5M |
Top Sellers
| 1 | -$27.5M | |
| 2 | -$20.2M | |
| 3 | -$19.6M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
-$17.2M |
| 5 |
FTM
First Turn Management
Del Mar,
California
|
-$13.3M |